May 2017 ARTICLE LIST >>
PharmaTutor (May - 2017)
ISSN: 2347 - 7881
(Volume 5, Issue 5)
Received On: 24/01/2017; Accepted On: 08/02/2017; Published On: 01/05/2017
AUTHORS:
Hnawate R.M*., Deore P.
Dr. Vedprakash Patil Pharmacy College,
Aurangabad,
Maharashtra, India
* ravi_hanwate@yahoo.co.in
ABSTRACT:
For the past few years, there has been a considerable research on the basis of Novel drug delivery system, using particulate vesicle systems as such drug carriers for small and large molecules. Nanoparticles, Liposomes, Microspheres, Niosomes, Pronisomes, Ethosomes, Proliposomes have been used as drug carrier in vesicle drug delivery system.
How to cite this article: Hnawate RM, Deore P; Nanoparticle - novel drug delivery system: A Review; PharmaTutor; 2017; 5(5); 9-23
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1.N. C Shinde; N.J Keskar; P. D Argade.RJPBCS., 2012, 3, 922.
2.Buzea C, Pacheco II, Robbie K. (2007). Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2 (4): MR17-MR71.
3.Roco MC, Bainbridge WS. (2005). Societal implications of nanoscience and nanotechnology: maximizing human benefit. Journal of Nanoparticle Research. 7 (1): 1-13.
4.Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res 2000; 33: 94-101.
5.Bhadra D, Bhadra S, Jain P, Jain NK. Pegnology: a review of PEG-ylated systems. Pharmazie 2002; 57: 5-29.
6.Kommareddy S, Tiwari SB, Amiji MM. Long-circulating polymeric nanovectors for tumor-selective gene delivery. Technol Cancer Res Treat 2005; 4: 615-25.
7.Lee M, Kim SW. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res 2005; 22: 1-10.
8.Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release. 70 (1): 1-20.
9.Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacological reviews. 53 (2): 283-318.
10.Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Maincent P, Kawashima Y, Lehr C-M. (2001). Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. Journal of Pharmacology and Experimental Therapeutics. 299 (2): 775-781.
11.Shivakumar H, Gowda D, Krishna R, Das D. (2005). Nanoparticles-Targeting neurotherapeutic agents through the blood brain barrier. INDIAN DRUGS-BOMBAY-. 42 (11): 709.
12.V.B. Kadam*, K.B. Dhanawade, V.A. Salunkhe, A.T. Ubale A. T. Journal of Current Pharma Research 4 (4), 2014, 1318-1335.
13.R.S.M. Krishna. Ind. J. Pharm. Educ. Res., 40, 1 (200) 615-9.
14.R. Sagar, A. Mudshinge. Saudi Pharmaceutical Journal, 19 (2011) 129–141.
15.Mohd Athar1*, Amar Jyoti Das2 Review ArticleAdv. Mater. Rev. 2014, 1(1), 25-37
16.VJ Mohanraj1* and Y Chen2 Research ArticleTropical Journal of Pharmaceutical Research, June 2006; 5 (1): 561-573
17.Kreuter J. Nanoparticles. In Colloidal drug delivery systems, J, K., Ed. Marcel Dekker: New York,1994; pp 219-342.
18.Reverchon E, Adami R. Nanomaterials and supercritical fluids. The Journal of Supercritical Fluids 2006; 37:1-22.
19.Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 2005; 127:10096-10100
20.Kompella UB, Bandi N, Ayalasomayajula SP. Poly (lactic acid) nanoparticles for sustained release of
budesonide. Drug Deliv.Technol. 2001; 1: 1-7.
21.Ravi MN, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004; 25: 1771-1777.
22.Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, Zhou JJ, Gao, XJ, PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-[alpha] carriers. J Control Release 2001; 71: 287-296.
23.Kwon, HY, Lee JY, Choi SW, Jang Y, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf. A: Physicochem. Eng. Aspects 2001;182: 123-130.
24.Zambaux M, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso M, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by double emulsion.
25.Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Preparation of biodegradable nanoparticles of water-soluble and insoluble drugs with D,Llactide/ glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J. Control. Release 1993; 25: 89-98.
26.Zhang Q, Shen Z, Nagai T. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int. J. Pharm. 2001; 218: 75-80.
27.Boudad H, Legrand P, Lebas G, Cheron M, Duchene D, Ponchel G. Combined hydroxypropyl-[beta]-
cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir. Int J. Pharm. 2001; 218: 113-124.
28.Puglisi G, Fresta M, Giammona G, Ventura CA. Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation.Int. J. Pharm. 1995; 125: 283-287.
29.Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoprticles as protein carriers. J. Appl. Polymer Sci. 1997; 63: 125-132.
30.Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997; 14: 1431-1436.
31.Prabhjot Kaur et al reaserch artical IJRPC 2012, 2(3)
32.http://www.pharmatutor.org/articles/novel-drug-delivery-system?page=4
33.Sarika Anand Jadhav*, Prof. Prashant Patil and Dr. Ramesh Kalkotwar Vol 5, Issue 10, 2016 wjpps. research article of NANOPARTICLES AS – PARTICULATE DRUG DELIVERY SYSTEM wjpps_.
34.Kedar Prasad Meena*, J.S. Dangi, P K Samal and Manoj Kumars review on
Nanoparticles Technology and Recent Advances in Novel Drug Delivery systems 2011; 1 (1): 1-5.
.png)
